Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Saad Insider Profile

11 Followers

Mark Saad, Director at Axsome Therapeutics, holds 11.73K shares in Axsome Therapeutics (Ticker: AXSM), holds 13.75K shares in Flyte Aviation (Ticker: VJET), holds 276.86K shares in Cerenome (Ticker: CNSY).

Mark Saad's Trading History

AXSM
Axsome Therapeutics
Jun 10, 2026DirectorUninformative Buy336.02K$1.57M
VJET
Flyte Aviation
Jan 07, 2021DirectorUninformative Buy―$5.73K
CNSY
Cerenome
Feb 04, 2013CFOUninformative Sell―$195.46K

You May Also Like

Mark Saad insider profile FAQ

What is the percentage of profitable transactions made by Mark Saad?
The percentage of profitable transactions made by Mark Saad is 100%.
What is the average return per transaction made by Mark Saad?
The average return per transaction made by Mark Saad is 141.90%.
What stocks does Mark Saad hold?
Mark Saad holds: AXSM, CNSY, VJET stocks.
What was Mark Saad’s latest transaction?
Mark Saad’s latest transaction was an Uninformative Buy of $336.02K.
What was Mark Saad's most profitable transaction?
Mark Saad’s most profitable transaction was an Informative Buy of AXSM stock on May 24, 2019. The return on the trade was 227.10%.
What is Mark Saad's role in Axsome Therapeutics?
Mark Saad's role in Axsome Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.